Key Takeaway: Johnson & Johnson will participate in the Bernstein’s 42nd Annual Strategic Decisions Conference. The event aims to discuss strategic decisions within the biopharma industry. Further details about the topics to be covered or key speakers have not been provided.
Price reaction · baseline $227.5 (2026-04-24 close) · 3 other JNJ headline(s) in the window, move may be shared
day 0 close · peak
-0.9%
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.6%
average across 15 past catalysts
Lead asset
Canagliflozin
Phase 3 · Diabetes Mellitus, Type 2
Full Press Release Details
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the Bernstein’s 42ndAnnual Strategic Decisions Conference on Wednesday, May 27th, 2026. Management will participate in a Fireside Chat at 11:00 a.m. Eastern Time.
A live audio webcast of the presentation will be accessible through Johnson & Johnson’s Investor Relations website atwww.investor.jnj.com. An archived edition of the session will be available later that day.
The audio webcast replay will be available approximately 48 hours after the webcast.